BofA Securities Reiterates Buy Rating on ASML
- Rating
- Buy
- Price target
- $2,268
- Implied upside
- +28%
- vs $1,777.77 prior close
BofA Securities analyst Didier Scemama reiterated a Buy rating and $2,268.00 price target on ASML (NASDAQ: ASML).
“ASML’s 2030 guide assumes €44-60bn of sales, 56-60% GM and €7.7-8.5bn OPEX.
Conceptually, should ASML deliver revenues in excess of €60bn in 2030 (we think €73bn is possible), it suggested that both GM and EBIT margins should be higher (with the same mix assumptions) as higher revenues better absorb fixed costs in GMs (c20% of COGS, we estimate), R&D grows in line with sales and SG&A grows slowly.
This opens the door to GMs above 60%, EBIT margins of 50% and EPS >€90 on or around 2030, in our view.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Tracking this call
Since this note+3% ASML $1,777.77 → $1,834.10 (Oct 7) · 11% of the way to the target
This callScored on Dec 10, 2026, six months after the note: did ASML reach $2,268?
Firm track recordBank of America reached 73% of its 41 scored targets within six months (#11 of 31 firms). Accuracy ranking →
